On Friday, the FDA approved Checkpoint Therapeutics, Inc.’s (NASDAQ:CKPT) Unloxcyt (cosibelimab-ipdl) for metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not ...

After hours: January 3 at 4:45:48 PM EST Loading Chart for CHKP ...

Another checkpoint inhibitor has entered the fray, as Checkpoint Therapeutics has passed the FDA’s checkpoint with its PD-L1 inhibitor cosibelimab. The FDA has approved cosibelimab under the ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Check Point Software Technologies Ltd. engages in the development and market of software and hardware solutions for information technology security. Its products include threat prevention ...

Zafrir, a former venture capital investor, replaces co-founder Gil Shwed, who had served as CEO of Check Point since its launch in 1993. Check Point Software Technologies said Monday that its ...

“Today’s FDA approval of Unloxcyt – the first marketing approval for our company…This approval marks Checkpoint’s transformation to a commercial-stage company, with the opportunity to ...

Dec 13 (Reuters) - The U.S Food and Drug Administration said on Friday it has approved Checkpoint Therapeutics' (CKPT.O), opens new tab drug for treatment of a type of cancer on the outer layer of ...

December 19, 2024 • Argentina's president Javier Milei cut 30,000 government jobs. The country's inflation rate dropped more than 20%, but poverty is soaring. Trump advisors Elon Musk and Vivek ...